Results 61 to 70 of about 720 (121)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

Clinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Efficacy and Safety of Topical Timolol in Localized Superficial Hemangiomas: A Prospective Controlled Open-label Study

Indian Journal of Paediatric Dermatology
Background: Infantile hemangiomas (IHs) are common vascular tumors of infancy that often regress spontaneously. However, early treatment may be required to prevent complications. This study evaluated the efficacy and safety of topical timolol maleate 0.5%
Sandipan Dhar, Safia Bashir, Abhijit Saha, Raghubir Banerjee, Rajib Malakar   +4 more
doaj   +1 more source

Effects of timolol treatment on pancreatic antioxidant enzymes in streptozotocin-induced diabetic rats: An experimental and computational study [PDF]

Journal of Medical Biochemistry, 2019
Background: The study aimed to investigate whether timolol-treatment has a beneficial effect on pentose phosphate pathway enzyme activities such as glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGDH) enzyme activities and ...
Nuray Ulusu Nuriye, Gok Muslum, Erman Burak, Turan Belma   +3 more
doaj  

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients

Clinical Ophthalmology, 2009
Makoto Ishikawa1,2, Takeshi Yoshitomi11Department of Ophthalmology, Akita University Faculty of Medicine, Akita, Japan; 2Department of Ophthalmology, Ogachi Central Hospital, Akita, JapanPurpose: To study the effect of the concomitant use of brinzolamide
Makoto Ishikawa, Takeshi Yoshitomi
doaj  

Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review

Frontiers in Pharmacology
BackgroundPropranolol, a nonselective β-blocker, is the first-line treatment for infantile hemangioma (IH). Topical timolol has recently been proposed as a novel IH treatment with fewer adverse effects.
Xiaoye Huang, Xiaoye Huang, Wenyue Si, Zhili Zou, Binyao Li, Yide Mu, Wei Zhong, Kaiying Yang   +7 more
doaj   +1 more source

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2014
Purvi Bhagat,1 Kalyani Sodimalla,2 Chandrima Paul,3 Surinder S Pandav,4 Ganesh V Raman,5 Rengappa Ramakrishnan,6 Abhijeet Joshi,7 Atul Raut7 1Glaucoma Clinic, M & J Western Regional Institute of Ophthalmology, Civil Hospital, Ahmedabad, Gujarat ...
Bhagat P, Sodimalla K, Paul C, Pandav SS, Raman GV, Ramakrishnan R, Joshi A, Raut A   +7 more
doaj  

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon

Clinical Ophthalmology, 2016
Jie Shen,1 Marina Bejanian2 1Department of Translational Sciences, 2Department of Ophthalmology Clinical Development, Allergan plc, Irvine, CA, USA Purpose: Many patients with glaucoma require combination therapies to achieve target intraocular ...
Shen J, Bejanian M
doaj  

Timolol for glaucoma.

Indian journal of ophthalmology, 1982
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Timolol and Glaucoma

Archives of Ophthalmology, 1981
To the Editor. —There is increasing evidence of systemic side effects secondary to topical ocular administration of timolol maleate for the treatment of glaucoma. 1,2 These systemic side effects are essentially the same as those seen from systemically administered β-blockers.
E M, Van Buskirk, F T, Fraunfelder
openaire   +2 more sources

Travoprost/Timolol

Drugs & Aging, 2006
Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F(2alpha) analogue travoprost and the beta-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta ...
Sheridan M, Hoy, Susan J, Keam, Gillian M, Keating   +2 more
openaire   +2 more sources